Windtree Therapeutics (WINT)
NASDAQ:WINT
US Market

Windtree Therapeutics (WINT) Stock Forecast & Price Target

162 Followers
See the Price Targets and Ratings of:
See bloggers sentiment and opinion on WINT
>

WINT Analyst Ratings

Currently, no data available
Based on 0 analysts giving stock ratings to
Windtree
Therapeutics
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

WINT Stock 12 Months Forecast

There Are No Analyst Ratings for WINT In The Last 3 Months.
Highest Price TargetAverage Price TargetLowest Price Target
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

WINT Financial Forecast

WINT Earnings Forecast

Next quarter’s earnings estimate for WINT is -$0.63 with a range of -$0.63 to -$0.63. The previous quarter’s EPS was -$1.64. WINT beat its EPS estimate 33.33% of the time in the past 12 months, while its overall industry beat the EPS estimate 58.69% of the time in the same period. In the last calendar year WINT has Underperformed its overall industry.
Next quarter’s earnings estimate for WINT is -$0.63 with a range of -$0.63 to -$0.63. The previous quarter’s EPS was -$1.64. WINT beat its EPS estimate 33.33% of the time in the past 12 months, while its overall industry beat the EPS estimate 58.69% of the time in the same period. In the last calendar year WINT has Underperformed its overall industry.

WINT Sales Forecast

Next quarter’s sales forecast for WINT is $0.00 with a range of $0.00 to $0.00. The previous quarter’s sales results were $0.00. WINT beat its sales estimates 0.00% of the time in past 12 months, while its overall industry beat sales estimates 44.67% of the time in the same period. In the last calendar year WINT has Underperformed its overall industry.
Next quarter’s sales forecast for WINT is $0.00 with a range of $0.00 to $0.00. The previous quarter’s sales results were $0.00. WINT beat its sales estimates 0.00% of the time in past 12 months, while its overall industry beat sales estimates 44.67% of the time in the same period. In the last calendar year WINT has Underperformed its overall industry.
No data currently available

WINT Analyst Recommendation Trends

WINT has not received any ratings in the last 3 months.
WINT has not received any ratings in the last 3 months.

Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
xxxxxxxxxxxxxxx
xxxxxxxxxxxxxxx
xxxxxxxxxxxxxxx
xxxxxxxxxxxxxxx
xxxxxxxxxxxxxxx
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

WINT Stock Forecast FAQ

What is WINT’s average 12-month price target, according to analysts?
Currently, no data Available
What is WINT’s upside potential, based on the analysts’ average price target?
Currently there's no upside potential for WINT, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
    How can I follow the stock ratings of top Wall Street analysts?
    Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
      Is WINT a Buy, Sell or Hold?
      Currently, no data Available
      What is Windtree Therapeutics’s price target?
      Currently, no data Available
      What do analysts say about Windtree Therapeutics?
      Not enough analysts have published a price target to provide an average price target.
      How can I buy shares of WINT?
      Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.

        What's Included in PREMIUM?
        Make informed decisions based on Top Analysts' activity
        Know what industry insiders are buying
        Get actionable alerts from top Wall Street Analysts
        Find out before anyone else which stock is going to shoot up
        Get powerful stock screeners & detailed portfolio analysis